Exploring Extended Adjuvant Endocrine Therapy for HR+ Breast Cancer

July 19, 2017
Hope S. Rugo, MD

Hope S. Rugo, MD, professor of medicine and director of the Breast Oncology Clinical Trials Program at the UCSF Helen Diller Family Comprehensive Cancer Center, discusses extended adjuvant endocrine therapy for patients with HR+ breast cancer.